Vol. 23 No. Special Issue 3 (2024): Mapana - Journal of Sciences
Research Articles

The Need and Importance of Augmented AI/ML systems for Health Claims Fraud Detection

Parul Naib
IIHMR University

Published 2024-11-06

Keywords

  • fraud,
  • artificial intelligence,
  • machine learning,
  • health insurance,
  • claims,
  • healthcare fraud
  • ...More
    Less

Abstract

Artificial Intelligence (AI) and Machine learning (ML) systems are increasingly being used to solve basic day-to-day problems. Chatbots such as Alexa and Siri play a big role in our day-to-day life with our reliance on these systems increasing by the day. The use of AI and ML systems is being increasingly explored, in fraud detection. particularly for the detection of fraud health insurance claims submitted by providers. Recently, several studies have leveraged AI/ML techniques to develop health claims fraud detection models with close to 100% accuracy rates. 

This paper looks at the limitations of the deep learning-based AI and ML models in the case of health claims fraud detection, and the associated challenges and implications. We then define an integrated AI/ML strategy augmented by human intelligence for  comprehensive fraud control to address the challenges and fraud detection using  AI/ML responsibly  without impacting the patient experience and health outcomes.

References

  1. GSMA, “State of Mobile Internet Connectivity Report-2020,” pp. 8–60, 2020.
  2. L. T. Khrais, “Role of artificial intelligence in shaping consumer demand in e-commerce,” Future Internet, vol. 12, no. 12, pp. 1–14, 2020, doi: 10.3390/fi12120226.
  3. V. A. Brei, “Machine learning in marketing,” Foundations and Trends in Marketing, vol. 14, no. 3, pp. 173–236, 2020, doi: 10.1561/1700000065.
  4. O. Arandjelovic, S. Stubseid, and O. A. Arandjelovi´c, “Machine Learning Based Prediction of Consumer Purchasing Decisions: The Evidence and Its Significance Surveillance,” Workshops at the Thirty-Second AAAI …, pp. 100–106, 2018.
  5. H. Shin, H. Park, J. Lee, and W. C. Jhee, “A scoring model to detect abusive billing patterns in health insurance claims,” Expert Systems with Applications, vol. 39, no. 8, pp. 7441–7450, 2012, doi: 10.1016/j.eswa.2012.01.105.
  6. H. He, J. Wang, W. Graco, and S. Hawkins, “Application of Neural Networks to Detection of Medical Fraud,” 1997.
  7. C. Francis, N. Pepper, and H. Strong, “Using support vector machines to detect medical fraud and abuse.,” Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference, pp. 8291–8294, 2011.
  8. T. Ekin, F. Leva, F. Ruggeri, and R. Soyer, “Application of bayesian methods in detection of healthcare fraud,” in Chemical Engineering Transactions, 2013, vol. 33, pp. 151–156. doi: 10.3303/CET1333026.
  9. Q. Liu and M. Vasarhelyi, “Healthcare fraud detection: A survey and a clustering model incorporating Geo-location information,” 2013.
  10. M. Kirlidog and C. Asuk, “A Fraud Detection Approach with Data Mining in Health Insurance,” Procedia - Social and Behavioral Sciences, vol. 62, pp. 989–994, 2012, doi: 10.1016/j.sbspro.2012.09.168.
  11. I. Kose, M. Gokturk, and K. Kilic, “An interactive machine-learning-based electronic fraud and abuse detection system in healthcare insurance,” Applied Soft Computing Journal, vol. 36, pp. 283–299, Aug. 2015, doi: 10.1016/j.asoc.2015.07.018.
  12. P. A. Ortega, C. J. Figueroa, and G. A. Ruz, “A Medical Claim Fraud/Abuse Detection System based on Data Mining: A Case Study in Chile,” 2006.
  13. J. M. Johnson and T. M. Khoshgoftaar, “Medicare fraud detection using neural networks,” J Big Data, vol. 6, no. 1, Dec. 2019, doi: 10.1186/s40537-019-0225-0.
  14. R. Y. Gupta, S. S. Mudigonda, and P. K. Baruah, “A comparative study of using various machine learning and deep learning-based fraud detection models for universal health coverage schemes,” International Journal of Engineering Trends and Technology, vol. 69, no. 3, pp. 96–102, 2021, doi: 10.14445/22315381/IJETT-V69I3P216.
  15. C. Zhang, X. Xiao, and C. Wu, “Medical fraud and abuse detection system based on machine learning,” Int J Environ Res Public Health, vol. 17, no. 19, pp. 1–11, 2020, doi: 10.3390/ijerph17197265.
  16. P. Babuna, X. Yang, A. Gyilbag, D. A. Awudi, D. Ngmenbelle, and D. Bian, “The impact of covid-19 on the insurance industry,” International Journal of Environmental Research and Public Health, vol. 17, no. 16, pp. 1–14, 2020, doi: 10.3390/ijerph17165766.
  17. A. Bollmann et al., “Utilization of in- And outpatient hospital care in Germany during the Covid-19 pandemic insights from the German-wide Helios hospital network,” PLoS ONE, vol. 16, no. 3 March, pp. 1–7, 2021, doi: 10.1371/journal.pone.0249251.
  18. O. Smith, P. Naib, P. K. Sehgal, and S. Chhabra, “PM-JAY Under Lockdown: Evidence on Utilization Trends,” World Bank, pp. 1–12, 2020.
  19. Transparency International, “Global Corruption Report 2006,” 2006. doi: 10.2307/j.ctt184qq53.
  20. K. J. Arrow, “Uncertainty and the Welfare Economics of Medical Care,” American Economic Review, vol. 53. pp. 941–696, 1963. doi: Article.
  21. K. Hussmann, “Addressing Corruption in the Health Sector: Securing Equitable Access to Health Care for Everyone,” U4 Issue, no. 1, p. 39, 2011.
  22. W. D. Savedoff, “Transparency and Corruption in the Health Sector : A Conceptual Framework and Ideas for Action in Latin American and the Caribbean,” Inter-American Development Bank, vol. Note 3, no. May, pp. 1–29, 2007.
  23. M. Sparrow, “Fraud Control in the Health Care Industry: Assessing the State of the Art,” National Institute of Justice Journal, vol. JR000235, no. 1042, p. 11, 1998.
  24. D. Thornton, M. Brinkhuis, C. Amrit, and R. Aly, “Categorizing and Describing the Types of Fraud in Healthcare,” Procedia Comput Sci, vol. 64, no. December, pp. 713–720, 2015, doi: 10.1016/j.procs.2015.08.594.
  25. R. Gaitonde, A. D. Oxman, P. O. Okebukola, and G. Rada, “Interventions to reduce corruption in the health sector,” Cochrane Database of Systematic Reviews, vol. 2016, no. 8. John Wiley and Sons Ltd, Aug. 16, 2016. doi: 10.1002/14651858.CD008856.pub2.
  26. P. C. Dean, J. Vazquez-Gonzalez, and L. Fricker, “Causes and Challenges of Healthcare Fraud in the US,” International Journal of Business and Social Science, vol. 4, no. 14, p. 4, 2013.
  27. J. D. Byrd, P. Powell, and D. L. Smith, “Health care fraud: an introduction to a major cost issue,” Journal of Accounting, Ethics & Public Policy Volume 14, No. 3, 2013.
  28. J. H. Zhao, X. Li, and Z. Y. Dong, “Online Rare Events Detection,” in Advances in Knowledge Discovery and Data Mining, 2007, pp. 1114–1121.
  29. A. Carreño, I. Inza, and J. A. Lozano, “Analyzing rare event, anomaly, novelty and outlier detection terms under the supervised classification framework,” Artificial Intelligence Review, vol. 53, no. 5, pp. 3575–3594, 2020, doi: 10.1007/s10462-019-09771-y.
  30. S. S. Waghade, “A Comprehensive Study of Healthcare Fraud Detection based on Machine Learning,” 2018.
  31. E. Wanyonyi, A. Rodrigues, S. Abeka, and S. Ogara, “Effectiveness Of Security Controls On Electronic Health Records,” INTERNATIONAL JOURNAL OF SCIENTIFIC & TECHNOLOGY RESEARCH, vol. 6, 2017.
  32. H. Shin, H. Park, J. Lee, and W. C. Jhee, “A scoring model to detect abusive billing patterns in health insurance claims,” Expert Systems with Applications, vol. 39, no. 8, pp. 7441–7450, Jun. 2012, doi: 10.1016/j.eswa.2012.01.105.
  33. J. R. Gaikwad, A. B. Deshmane, H. V Somavanshi, S. V Patil, and R. A. Badgujar, “Credit Card Fraud Detection using Decision Tree Induction Algorithm,” International Journal of Innovative Technology and Exploring Engineering (IJITEE), no. 6, pp. 2278–3075, 2014.
  34. J. T. Hancock and T. M. Khoshgoftaar, “Gradient Boosted Decision Tree Algorithms for Medicare Fraud Detection,” SN Computer Science, vol. 2, no. 4, pp. 1–12, 2021, doi: 10.1007/s42979-021-00655-z.
  35. H. He, J. Wang, W. Graco, and S. Hawkins, “Application of Neural Networks to Detection of Medical Fraud,” 1997.
  36. U. Srinivasan and B. Arunasalam, “Leveraging big data analytics to reduce healthcare costs,” IT Prof, vol. 15, no. 6, pp. 21–28, 2013, doi: 10.1109/MITP.2013.55.
  37. T. Vian, “Review of corruption in the health sector: Theory, methods and interventions,” Health Policy Plan, vol. 23, no. 2, pp. 83–94, 2008, doi: 10.1093/heapol/czm048.
  38. S. P. Sood et al., “Electronic medical records: A review comparing the challenges in developed and developing countries,” Proceedings of the Annual Hawaii International Conference on System Sciences, no. November 2015, 2008, doi: 10.1109/HICSS.2008.141.
  39. G. Rieder and J. Simon, “Big Data: A New Empiricism and its Epistemic and Socio-Political Consequences,” Berechenbarkeit der Welt?, pp. 85–105, 2017, doi: 10.1007/978-3-658-12153-2_4.
  40. J. Burrell, “How the machine ‘thinks’: Understanding opacity in machine learning algorithms,” Big Data and Society, vol. 3, no. 1, pp. 1–12, 2016, doi: 10.1177/2053951715622512.
  41. M. T. Ribeiro, S. Singh, and C. Guestrin, “‘Why should i trust you?’ Explaining the predictions of any classifier,” Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, vol. 13-17-Augu, pp. 1135–1144, 2016, doi: 10.1145/2939672.2939778.
  42. C. Chaix-Couturier, I. Durand-Zaleski, D. Jolly, and P. Durieux, “Effects of financial incentives on medical practice: Results from a systematic review of the literature and methodological issues,” International Journal for Quality in Health Care, vol. 12, no. 2, pp. 133–142, Apr. 2000, doi: 10.1093/intqhc/12.2.133.
  43. J. Clemens and J. D. Gottlieb, “Do physicians’ financial incentives affect medical treatment and patient health?,” SIEPR Discussion Paper No. 11-017, vol. 104, no. 4, pp. 1320–1349, 2012, doi: 10.1257/aer.104.4.1320.
  44. H. He, J. Wang, W. Graco, and S. Hawkins, “Application of Neural Networks to Detection of Medical Fraud,” 1997.
  45. U. Office of the Inspector General, Department of Health and Human Services, “2020 National HealthCare Fraud Takedown. Accessed at https://oig.hhs.gov/newsroom/media-materials/2020takedown/ on 24th Jan 2022,” 2020.
  46. Europäisches Parlament, The ethics of artificial intelligence issues and initiatives : study Panel for the Future of Science and Technology, no. March. 2020.
  47. V. Gawron, “Automation in Aviation — Accident Analaysis,” MITRE Technical Report, no. 16, 2019.
  48. H. J. Wilson and P. R. Daugherty, “Collaborative Intelligence: Humans and AI Are Joining Forces. Accessed at https://hbr.org/2018/07/collaborative-intelligence-humans-and-ai-are-joining-forces on 18th Nov 2021,” Harvard Business Review July–August 2018, 2018.
  49. OECD Centre for Responsible Business Conduct, “Artificial Intelligence and Responsible Business Conduct. Accessed at https://mneguidelines.oecd.org/RBC-and-artificial-intelligence.pdf on 19th Nov 2021,” pp. 1–9, 2019.
  50. D. Wang et al., “Human-AI collaboration in data science: Exploring data scientists’ perceptions of automated AI,” Proc ACM Hum Comput Interact, vol. 3, no. CSCW, 2019, doi: 10.1145/3359313.
  51. T. Kanakubo and H. Kharrazi, “Comparing the Trends of Electronic Health Record Adoption Among Hospitals of the United States and Japan,” Journal of Medical Systems, vol. 43, no. 7, 2019, doi: 10.1007/s10916-019-1361-y.
  52. Y.-G. Kim et al., “Rate of electronic health record adoption in South Korea: A nation-wide survey.,” International journal of medical informatics, vol. 101, pp. 100–107, May 2017, doi: 10.1016/j.ijmedinf.2017.02.009.
  53. M. Esdar, J. Hüsers, J.-P. Weiß, J. Rauch, and U. Hübner, “Diffusion dynamics of electronic health records: A longitudinal observational study comparing data from hospitals in Germany and the United States.,” International journal of medical informatics, vol. 131, p. 103952, Nov. 2019, doi: 10.1016/j.ijmedinf.2019.103952.
  54. J. Liang et al., “Adoption of Electronic Health Records (EHRs) in China During the Past 10 Years: Consecutive Survey Data Analysis and Comparison of Sino-American Challenges and Experiences.,” Journal of medical Internet research, vol. 23, no. 2, p. e24813, Feb. 2021, doi: 10.2196/24813.
  55. Y. H. Su, C. P. Chao, L. C. Hung, S. F. Sung, and P. J. Lee, “A natural language processing approach to automated highlighting of new information in clinical notes,” Applied Sciences (Switzerland), vol. 10, no. 8, 2020, doi: 10.3390/APP10082824.
  56. Y. Juhn and H. Liu, “Artificial intelligence approaches using natural language processing to advance EHR-based clinical research,” Journal of Allergy and Clinical Immunology, vol. 145, no. 2, pp. 463–469, 2020, doi: 10.1016/j.jaci.2019.12.897.
  57. K. Patel, S. M. Drucker, J. Fogarty, A. Kapoor, and D. S. Tan, “Using multiple models to understand data,” IJCAI International Joint Conference on Artificial Intelligence, pp. 1723–1728, 2011, doi: 10.5591/978-1-57735-516-8/IJCAI11-289.
  58. A. Bonarini, “A Multimodel Approach to Reasoning and Simulation,” IEEE Transactions on Systems, Man and Cybernetics, vol. 24, no. 10, pp. 1433–1449, 1994, doi: 10.1109/21.310527.
  59. Y. T. Park, J. S. Yoon, S. M. Speedie, H. Yoon, and J. Lee, “Health insurance claim review using information technologies,” Healthcare Informatics Research, vol. 18, no. 3, pp. 215–224, 2012, doi: 10.4258/hir.2012.18.3.215.
  60. Centre for Medicare and Medicaid, “MIP Medicaid Integrity Program National Medicaid Audit Program,” no. November, 2012.
  61. National Health Authority, “Ayushman Bharat PM-JAY Anti Fraud Guidelines. Accessed at https://pmjay.gov.in/sites/default/files/2018-08/Anti-fraud-PMJAY-Guidelines.pdf on 22nd Sep 2021,” 2018.
  62. GAO - U.S. Government Accountability Office, “A Framework for Managing Fraud Risks in Federal Programs,” International Journal of …, no. July, p. 61, 2015.